Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00618007 · ClinicalTrials.gov registry record · Phase 2
Effect of PF-00734200 in Subjects With Type 2 Diabetes
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 289
- Enrollment target
NCT00618007 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 289 participants.
The verdict
NCT00618007, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 289 participants
- Enrollment target
Study Summary
To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin
Interventions
- DRUG Placebo
- DRUG PF-00734200 30 mg QD
- DRUG PF-00734200 20 mg QD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00618007
The ClinicalTrials.gov registry entry for NCT00618007 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00618007 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00618007 about?
NCT00618007 is a clinical study titled "Effect of PF-00734200 in Subjects With Type 2 Diabetes". To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin
What is the current status of trial NCT00618007?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 289 participants. The study started on 2008-02. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00618007?
The interventions under investigation include: Placebo (DRUG), PF-00734200 30 mg QD (DRUG), PF-00734200 20 mg QD (DRUG).
Who is sponsoring clinical trial NCT00618007?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.